Customized research for ARPO vs. OMER!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for ARPO vs. OMER.


↗ Join Our Free Email Newsletter.




Your Mobile Phone Number:

Aerpio Pharmaceuticals Inc. vs. Omeros Corporation

ARPO
Data Last Updated: 16 hours ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 45.459M


P/E: N/A

P/S: N/A

Q P/B: 1.38

Y Rev: -

Q Rev: -

Beta: 1.83

Industry

Health Care/Life Sciences

ARPO Share Stats

Outstanding Shares

40.59M

Float Shares

32.93M

Percent of Float Short

1.98%

ARPO Insider Stats

Percent Outstanding Insider Ownership

1.91%

Percent Outstanding Institution Ownership

6.47%

ARPO Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

ARPO in Pulse Portal

Stream of Posts

ARPO Symbol Page

Share ARPO Insights

Express Sentiment

'Buy' or 'Sell' ARPO

ARPO Profile

CEO

Mr. Muneer A. Satter

Exchange

Nasdaq

Employees

N/A

About

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company, which engages in the research and development of treatments for ocular diseases. Its product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial...

ARPO Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(23.27M)

Cash Flow Statement

Change in Cash / Investments

-

Balance Sheet

Cash / Investments

38.53M

Short Term Debt

103,000

Long Term Debt

None

Total Current Assets

39.57M

Total Current Liabilities

3.34M

Total Assets

39.94M

Total Liabilities

3.4M

Stockholder Equity

36.54M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(3.92M)

Cash Flow Statement

Q Change in Cash / Investments

(3.94M)

Balance Sheet

Q Cash / Investments

34.58M

Q Short Term Debt

107,000

Q Long Term Debt

None

Q Total Current Assets

35.39M

Q Total Current Liabilities

2.65M

Q Total Assets

35.7M

Q Total Liabilities

2.69M

Q Stockholder Equity

33.01M

ARPO Charts

10-Year Chart

ARPO 10-Year Chart

5-Year Chart

ARPO 5-Year Chart

1-Year Chart

ARPO 1-Year Chart

6-Month Chart

ARPO 6-Month Chart

3-Month Chart

ARPO 3-Month Chart

1-Month Chart

ARPO 1-Month Chart

1-Day Chart

ARPO 1-Day Chart

OMER
Data Last Updated: 15 hours ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 811.119M


P/E: N/A

P/S: 7.25

Q P/B: N/A

Y Rev: 111.81M

Q Rev: 23.54M

Beta: 1.93

Industry

31,458

OMER Share Stats

Outstanding Shares

54.51M

Float Shares

51.78M

Percent of Float Short

21.09%

OMER Insider Stats

Percent Outstanding Insider Ownership

4.75%

Percent Outstanding Institution Ownership

23.3%

OMER Social Stats

Followers

2

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

OMER in Pulse Portal

Stream of Posts

OMER Symbol Page

Share OMER Insights

Express Sentiment

'Buy' or 'Sell' OMER

OMER Profile

CEO

Dr. Gregory A. Demopulos

Exchange

Nasdaq

Employees

258.00

About

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous syst...

OMER Financials

Annual Financials

Income Statement

Revenue

111.81M

Net Income

(84.49M)

Cash Flow Statement

Change in Cash / Investments

(2.78M)

Balance Sheet

Cash / Investments

60.79M

Short Term Debt

2.28M

Long Term Debt

158.21M

Total Current Assets

103.75M

Total Current Liabilities

55.46M

Total Assets

136.97M

Total Liabilities

245.99M

Stockholder Equity

(109.02M)

Quarterly Financials

Income Statement

Q Revenue

23.54M

Q Net Income

(29.03M)

Cash Flow Statement

Q Change in Cash / Investments

4.03M

Balance Sheet

Q Cash / Investments

53.98M

Q Short Term Debt

None

Q Long Term Debt

160.75M

Q Total Current Assets

85.61M

Q Total Current Liabilities

57.94M

Q Total Assets

118.21M

Q Total Liabilities

250.08M

Q Stockholder Equity

(131.86M)

OMER Charts

10-Year Chart

OMER 10-Year Chart

5-Year Chart

OMER 5-Year Chart

1-Year Chart

OMER 1-Year Chart

6-Month Chart

OMER 6-Month Chart

3-Month Chart

OMER 3-Month Chart

1-Month Chart

OMER 1-Month Chart

1-Day Chart

OMER 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon